WaferGen Biosystems, Inc. announced that the validation results of the SmartChip Real-Time PCR System will be presented at Cambridge Healthcare Institute’s 16th International Molecular Medicine Tri-Conference at San Francisco. The data will be presented by WaferGen scientists and collaborative researchers from the University of Pittsburgh School of Medicine. The presentation titled “High-Density, Nano-Volume SmartChip System for Real-Time Gene Expression Analysis” provides an overview of the company’s novel whole genome, high-throughput SmartChip Real-Time PCR System, as well as data related to the system’s performance as demonstrated in ongoing alpha testing. WaferGen’s SmartChip alpha testing program, which is being conducted at the University of Pittsburgh School of Medicine, involves the study of RNA isolated from lung tissue samples from healthy patients, as well as patients with chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). Researchers are screening these RNA samples with the SmartChip Real-Time PCR System in order to assess the platform’s performance in conducting novel gene expression research.